A
Alpine Immune Sciences Inc
SWB:34LA
Alpine Immune Sciences Inc
SWB:34LA
Price:
58.5
EUR
Market Cap:
€330.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Alpine Immune Sciences Inc
SWB:34LA
|
US |
|
B
|
Barco NV
OTC:BCNAY
|
BE |
|
N
|
Nov Inc
XMUN:NO8
|
US |
|
B
|
Bruker Corp
XBER:BKD
|
US |
|
E
|
Exor NV
VSE:EXO
|
NL |
|
V
|
Valero Energy Corp
LSE:0LK6
|
US |
|
Teva Pharmaceutical Industries Ltd
F:TEV
|
IL |
|
N
|
New Gold Inc
XMUN:32N
|
CA |
|
DREAM Unlimited Corp
F:50DA
|
CA |
|
LTIMindtree Ltd
NSE:LTIM
|
IN |
|
DeFi Development Corp
F:F6S0
|
US |
|
Graphite India Ltd
NSE:GRAPHITE
|
IN |
|
M
|
MFA Financial Inc
F:M4Z
|
US |
|
B
|
Boston Scientific Corp
DUS:BSX
|
US |
|
A
|
AK Alrosa PAO
MOEX:ALRS
|
RU |
|
F
|
Fastenal Co
SWB:FAS
|
US |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 34LA's stock price target?
Not Available
34LA does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Alpine Immune Sciences Inc?
Projected CAGR
-15%
-15%
Over the last 8 years, the compound annual growth rate for Revenue has been 82%. The projected CAGR for the next 1 year is -15%.
